TSHR and geroderma osteodysplastica: In a prospective study of consecutive GO patients, novel cell‐based TSHR‐Ab bioassays measuring stimulatory TSHR‐Ab showed higher sensitivity and specificity than commonly used immunoassays in differentiating clinically active from inactive, and mild from moderate‐to‐severe, GO [31].